Data Snapshot: Sep 06, 2026
$50K+

Aug-2026

Sales

Growth

Trend

6-Month

7

Product Count

SKUs

$32.98

Avg Price

117.7%

YoY Sales Change

-38.7%

YoY Price Change

Canna Clinicals

Where to Buy

Canna Clinicals is stocked at 10 licensed dispensaries across New York, with the deepest coverage in New York, Bellport, Brooklyn, Canandaigua, and Medford. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.

https://headsetstorage.blob.core.windows.net/brand-stores/12298.json?v=20260905
Canna Clinicals Sales

Market Insights Snapshot

Canna Clinicals Historical Sales by Category

Canna Clinicals concentrated 80.41% of August 2026 sales in Tincture & Sublingual, where year-over-year growth was 87.69% and month-over-month growth was 9.69%, while Capsules rose 170.04% YoY with a 26.86% MoM lift to 8.36% share and Topical expanded 34.49% MoM to 11.23% share without a reported YoY figure. Despite brand-level sales up 117.67% YoY alongside a 38.68% YoY drop in average price, the mix stayed tilted toward higher-ticket Tincture & Sublingual at a $34.21 average price versus $20.74 in Capsules, implying that August 2026 growth came from both depth in Tincture & Sublingual and breadth from fast-rising Capsules, with Topical adding incremental volume.

Positioning-wise, maintaining a 80.41% mix in Tincture & Sublingual while ranking 6 in New York suggests a specialist stance anchored in that category, yet the 170.04% YoY surge in Capsules and 34.49% MoM expansion in Topical indicate diversification levers that can rebalance reliance if Tincture momentum slows. The combination of a 9.69% MoM gain in Tincture & Sublingual and a steeper 26.86% MoM in Capsules points to whitespace in value-oriented formats at a $20.74 average price, implying near-term share capture potential outside the core while the Tincture & Sublingual anchor defends current rank.

Aug-2026 Rank
Tincture & Sublingual
6
Category
Share of Sales
Avg Item Price
YoY %
MoM %
Tincture & Sublingual
80.4%
$34.21
+87.7%
+9.7%
Topical
11.2%
$40.27
+34.5%
Capsules
8.4%
$20.74
+170.0%
+26.9%
Canna Clinicals

Competitive Landscape

Canna Clinicals sits at rank #6 in New York Tincture & Sublingual in August 2026, improving 4 positions year over year from #10 and edging up 2 spots since May 2026 from #8 to #6. This matches its peak rank of #6 in August 2026 while the competitive set is mixed: Ayrloom held steady at #1 with a 5.2% YoY sales increase, and OMO - Open Minded Organics improved rank from #6 to #5 despite a -26.4% YoY sales decline, indicating Canna Clinicals’ rank gains came amid divergent competitor trajectories. Meanwhile, Head & Heal stayed #2 with a -24.7% YoY sales change and Veterans Choice Creations (VCC) held #4 with a 2.1% YoY increase, placing Canna Clinicals between peers moving in both directions and implying its upward rank path is driven more by relative share capture than category-wide expansion, a setup that suggests further small rank moves are plausible but will depend on displacements rather than broad demand growth.

Canna Clinicals market ranking for NY Tincture & Sublingual

Canna Clinicals

Notable Products

CBD/THC 5:1 Balance Tincture (100mg CBD, 500mg THC) posted the standout move in August 2026 with a +303.7% month-over-month surge, yet it sat at rank 6 while the CBD/THC 1:10 Max Strength Tincture (100mg CBD, 1000mg THC, 30ml) held rank 1 with only +2.9%. The CBD/CBN/THC 2:2:1 Sleep Tincture (300mg CBD, 300mg CBN, 150mg THC) climbed +58.4% to rank 2, and three of the top six are Tincture & Sublingual SKUs, signaling category concentration at the top of the lineup. With Capsules at ranks 4 and 7 growing +27.2% and +5.1% but not displacing tinctures, the mix points to a strategy anchored on high-THC and multi-cannabinoid tinctures, using smaller but fast-rising variants to broaden reach while defending the flagship.

Product
Category
Apr-2026
May-2026
Jun-2026
Jul-2026
Aug-2026
MoM %
CBD/THC 1:10 Max Strength Tincture (100mg CBD, 1000mg THC, 30ml)
Tincture & Sublingual
1
1
1
1
1
+2.9%
CBD/CBN/THC 2:2:1 Sleep Tincture (300mg CBD, 300mg CBN, 150mg THC)
Tincture & Sublingual
5
3
3
4
2
+58.4%
CBD/THC Unwind Tincture (1050mg CBD, 90mg THC, 15ml)
Tincture & Sublingual
3
2
4
2
3
+20.6%
CBD/THC 1:1 Max Strength Capsules 10-Pack (100mg CBD, 100mg THC)
Capsules
2
4
2
3
4
+27.2%
CBD/THC 1:1 Soothe Cream (1000mg CBD, 1000mg THC)
Topical
5
6
>10
5
5
+34.5%
CBD/THC 5:1 Balance Tincture (100mg CBD, 500mg THC)
Tincture & Sublingual
4
5
>10
6
6
+303.7%
CBD/THC/CBG1:1:1 Relief Complex Capsules 20-Pack (100mg CBD, 100mg THC, 100mg CBG)
Capsules
7
8
5
7
7
+5.1%
CBD/THC/CBN 1:1:1 Sleep Complex Capsules 20-Pack (100mg CBD, 100mg THC, 100mg CBN)
Capsules
6
7
6
>10
>10
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market